As a dynamic healthcare leader, we are committed to redefining healthcare standards and transforming lives through a comprehensive portfolio of innovative solutions, including rare diseases, plasma-derived products, orthopedics, medical devices, ophthalmology, and specialty therapeutics.

As a leading provider of plasma-derived products in the GCC region, AKSIA has a proven track record of consistently supplying essential products like immunoglobulin and human albumin to governmental and private healthcare institutions across the region, particularly in Saudi Arabia and Kuwait. Our expertise in market access and regulatory affairs ensures a reliable supply, even during challenging times.